Benlysta - NDC Database
5 records found
Page:
12064-009 Mar 10, 2011
Benlysta 120 mg/1.5ml Intravenous Injection, Powder, Lyophilized, for Solution by Glaxosmithkline Manufacturing Spa
Benlysta 120 mg/1.5ml Intravenous Injection, Powder, Lyophilized, for Solution by Glaxosmithkline Manufacturing Spa
12064-010 Mar 10, 2011
Benlysta 400 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Glaxosmithkline Manufacturing Spa
Benlysta 400 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Glaxosmithkline Manufacturing Spa
49401-101 Mar 10, 2011
Benlysta 120 mg/1.5ml Intravenous Injection, Powder, Lyophilized, for Solution by Human Genome Sciences, Inc.
Benlysta 120 mg/1.5ml Intravenous Injection, Powder, Lyophilized, for Solution by Human Genome Sciences, Inc.
49401-102 Mar 10, 2011
Benlysta 400 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Human Genome Sciences, Inc.
Benlysta 400 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Human Genome Sciences, Inc.
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.